See all treatments in the PatientsLikeMe system shared by patients just like you.
Brand Names:
Mirapex, Mirapexin, Novo-Pramipexole, Pexola, Sifrol
What is Pramipexole? Pramipexole has similar effects of dopamine, a naturally occurring chemical in the body. Low levels of dopamine are associated with Parkinson's disease (PD). It is used to treat PD symptoms, such as stiffness, tremors, muscle spasms, and poor muscle control; also to treat restless legs syndrome.
See more information, including instructions, precautions, side effects, and interactions.
466 patients in the community are taking or have taken Pramipexole.
| Reason | # Patients | Percentage of patients |
|---|---|---|
| Treat Parkinson's | 351 | 75% |
| Other | 22 | 4% |
| Stiffness/spasticity | 14 | 3% |
| Slowness | 8 | 1% |
| tremor | 6 | 1% |
| disease-related symptoms | 4 | <1% |
| Don't know | 3 | <1% |
| Mobility | 3 | <1% |
| restless legs | 2 | <1% |
| General health | 2 | <1% |
| Fatigue | 2 | <1% |
| Brandykinesia | 1 | <1% |
| Insomnia | 1 | <1% |
| Tremor, left hand, wrist and arm | 1 | <1% |
| Depression | 1 | <1% |
| Anxiety | 1 | <1% |
| 0 mg Daily | 0 Daily | 1.5 mg All the time (24/7) | 4 mg Daily | 0.1 mg Daily | 0.125 mg Daily | 0.15 mg Daily | 0.25 mg Daily | 0.3 mg Daily | 0.375 mg Daily | 0.5 mg Daily | 0.5 Daily | 0.75 mg Daily | 1 mg As needed | 1 mg Daily | 1 tbs. Daily | 1 Daily | 1.08 mg Daily | 1.25 mg Daily | 1.4 mg Daily | 1.5 mg Daily | 1.5 Daily | 1.75 mg Daily | 1.875 mg Daily | 2 mg Daily | 2.25 mg Daily | 2.5 mg Daily | 2.64 mcg Daily | 2.8 mg Daily | 3 mg Daily | 3 Daily | 3.25 mg Daily | 3.5 mg Daily | 3.75 mg Daily | 3.75 Daily | 4 mg Daily | 4.25 mg Daily | 4.5 mg Daily | 5 mg Daily | 6 mg Daily | 6 Daily | 6.5 mg Daily | 7.5 mg Daily | 9 mg Daily | 20 mg Daily | 25 mg Daily | 27.5 mg Daily | 50 Daily | 75 mg Daily | 100 mg Daily | 200 other Daily | 200 Daily | 225 mg Daily | 300 mg Daily | 500 mg Daily | 750 mg Daily | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
5
|
6
|
1
|
1
|
1
|
5
|
1
|
4
|
1
|
10
|
12
|
1
|
15
|
1
|
25
|
1
|
1
|
1
|
2
|
2
|
44
|
1
|
1
|
1
|
13
|
15
|
6
|
1
|
1
|
60
|
1
|
1
|
3
|
1
|
1
|
18
|
1
|
47
|
5
|
13
|
1
|
1
|
1
|
1
|
2
|
2
|
1
|
1
|
4
|
1
|
1
|
1
|
1
|
3
|
1
|
1
|
||
How long current patients have been taking Pramipexole or how long patients were taking Pramipexole before stopping.
Results from 62 patient evaluations. See the overall results and all individual evaluations.
| Major | 22% | 11 |
|---|---|---|
| Moderate | 48% | 24 |
| Slight | 20% | 10 |
| None | 6% | 3 |
| Can't tell | 4% | 2 |
Treat Parkinson's
| Severe | 15% | 9 |
|---|---|---|
| Moderate | 37% | 23 |
| Mild | 19% | 12 |
| None | 29% | 18 |
Top reported side-effects include: drowisness, Weight gain, Insomnia
Summary results are based on 62 individual responses. For more information, see overall results for Adherence, Burden and Cost.